Your browser doesn't support javascript.
loading
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study.
Bachy, Emmanuel; Savage, Kerry J; Huang, Huiqiang; Kwong, Yok-Lam; Gritti, Giuseppe; Zhang, Qingyuan; Liberati, Anna Marina; Cao, Junning; Yang, Haiyan; Hao, Siguo; Hu, Jianda; Zhou, Keshu; Petrini, Mario; Russo, Filomena; Zhang, Huilai; Sang, Wei; Ji, Jie; Ferreri, Andrés José María; Damaj, Gandhi Laurent; Liu, Hui; Zhang, Wei; Ke, Xiaoyan; Ghiggi, Chiara; Huang, Sha; Li, Xiaotong; Yao, Hui; Paik, Jason; Novotny, William; Zhou, Wenxiao; Zhu, Hongjie; Zinzani, Pier Luigi.
Afiliación
  • Bachy E; Hematology Department, Lyon Sud Hospital and Claude Bernard Lyon 1 University, Lyon, France.
  • Savage KJ; Division of Medical Oncology, University of British Columbia, BC Cancer, Vancouver, Canada.
  • Huang H; Sun Yat-Sen University Cancer Center, Guangzhou, China.
  • Kwong YL; Queen Mary Hospital, Hong Kong SAR, China.
  • Gritti G; ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Zhang Q; Harbin Medical University Cancer Hospital, Harbin, China.
  • Liberati AM; Azienda Ospedaliera Santa Maria Terni, Terni, Italy.
  • Cao J; Fudan University Shanghai Cancer Center, Shanghai, China.
  • Yang H; The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.
  • Hao S; Xin Hua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Hu J; Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fuzhou, China.
  • Zhou K; Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Petrini M; Azienda Ospedaliero Universitaria Pisana, Stabilimento di Santa Chiara, Pisa, Italy.
  • Russo F; Ospedale Maggiore, Ematologia e Centro Trapianti Midollo Osseo (CTMO), AOU Parma, Parma, Italy.
  • Zhang H; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
  • Sang W; The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Ji J; West China Hospital, Sichuan University, Chengdu, China.
  • Ferreri AJM; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Damaj GL; Institut d'Hematologie de Basse Normandie, Caen, France.
  • Liu H; Beijing Hospital, Beijing, China.
  • Zhang W; Peking Union Medical College Hospital, Beijing, China.
  • Ke X; Peking University Third Hospital, Beijing, China.
  • Ghiggi C; Ospedale Policlinico San Martino, Genoa, Italy.
  • Huang S; BeiGene (Shanghai) Co Ltd, Shanghai, China.
  • Li X; BeiGene (Shanghai) Co Ltd, Shanghai, China.
  • Yao H; BeiGene (Shanghai) Co Ltd, Shanghai, China.
  • Paik J; BeiGene USA, Inc, San Mateo, CA.
  • Novotny W; BeiGene USA, Inc, San Mateo, CA.
  • Zhou W; BeiGene (Shanghai) Co Ltd, Shanghai, China.
  • Zhu H; BeiGene (Shanghai) Co Ltd, Shanghai, China.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli," Bologna, Italy.
Blood Adv ; 7(16): 4435-4447, 2023 08 22.
Article en En | MEDLINE | ID: mdl-37276067
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T / Micosis Fungoide Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Linfoma Cutáneo de Células T / Micosis Fungoide Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Francia